Advanced Tissue

Advanced Tissue is a company focused on chronic wound care, providing specialized treatment solutions that enhance healing for various types of wounds, primarily serving seniors and healthcare institutions. Founded in 2000 and headquartered in Little Rock, US, Advanced Tissue specializes in chronic wound care solutions. The company has engaged in a single investment deal. The details of the founder and management team are not publicly available.

In September 2015, Ancor Capital Partners and Yukon Partners invested in Advanced Tissue, although financial terms were not disclosed. Advanced Tissue specializes in chronic wound care and treatment solutions tailored primarily for seniors. Their core offerings include a range of wound management products designed to facilitate the healing process and address various types of wounds. The company provides educational resources, essential oils, and specialized dressing products that are effective in managing and healing wounds.

Their products are aimed at healthcare providers, caregivers, and patients in need of effective wound care solutions, primarily within the United States and select international markets. By focusing on improving patient outcomes, Advanced Tissue serves a diverse clientele that includes hospitals, nursing homes, and home care providers, ensuring they meet the critical needs of their end users. Advanced Tissue generates revenue through direct sales of its wound care products and educational resources to healthcare facilities and consumers. Transactions are structured as B2B sales, with hospitals and care facilities purchasing products in bulk to manage their patient care needs effectively.

Additionally, the company may engage in partnerships with retailers and distributors to expand their reach in the market. The pricing structure varies based on product type, with specific offerings designed for different wound care requirements. Advanced Tissue's flagship products include specialized dressings and therapeutic solutions, which are positioned to provide value and enhance healing efficacy for their customers. Advanced Tissue is strategizing for future growth by developing new wound care products and techniques aimed at improving patient outcomes.

The company is also planning to expand its market presence in the international arena. The recent investment from Ancor Capital Partners and Yukon Partners in September 2015 will be utilized to support these product development and market expansion initiatives.